These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis. Mbuyi JM; Dequeker J; Teblick M; Merlevede M J Rheumatol; 1982; 9(4):579-83. PubMed ID: 7131456 [TBL] [Abstract][Full Text] [Related]
5. [Excretion of hydroxyproline in chronic polyarthritis]. Wessel G; Bretzke G; Bretzke K Z Rheumaforsch; 1970; 29(7):203-10. PubMed ID: 4108122 [No Abstract] [Full Text] [Related]
6. [Urinary hydroxyproline excretion in generalized bone diseases]. Czitober H; Raab W Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579 [No Abstract] [Full Text] [Related]
8. [Clinical significance of hydroxyproline determination in the urine in rheumatoid arthritis]. Eisner M; Wysocka K; Kondraciuk A; Czalczyńska A Reumatologia; 1969; 7(3):225-31. PubMed ID: 5367154 [No Abstract] [Full Text] [Related]
9. [The role of the urinary hydroxyproline level in the screening for collagen diseases]. Gambella GR; Zunino M Minerva Med; 1986 Apr; 77(16):607-12. PubMed ID: 3703359 [TBL] [Abstract][Full Text] [Related]
10. [Collagen metabolism in combined therapy of rheumatoid arthritis]. Weimann G; Burkhardt H; Rommel K; Wepler R Med Klin; 1973 Mar; 68(11):344-50. PubMed ID: 4348084 [No Abstract] [Full Text] [Related]
11. [Clinical value of hydroxyproline determination in the differential diagnosis between degenerative joint disease and rheumatoid arthritis]. Wysocka K; Krzyzanowska B Reumatologia; 1973; 11(4):341-3. PubMed ID: 4768292 [No Abstract] [Full Text] [Related]
12. [The behavior of hydroxyproline in urine in rheumatic children and their families]. Vedovini F; Pieri J; Gorelli L Riv Clin Pediatr; 1966 Dec; 78(6):744-57. PubMed ID: 5999595 [No Abstract] [Full Text] [Related]
13. [Various indices of collagen metabolism in children with rheumatoid arthritis]. Iakovleva AA; Gordeeva GF; Guseva ED Pediatriia; 1991; (5):58-61. PubMed ID: 1866241 [TBL] [Abstract][Full Text] [Related]
14. [Urinary secretion of hydroxyproline in early stages of adjuvant arthritis in the rat]. Abramovici J; Jonckheer M; Orloff S; Rao VH; Verbruggen L J Belge Rhumatol Med Phys; 1975; 30(4):193-207. PubMed ID: 1223116 [No Abstract] [Full Text] [Related]
15. [The clinical significance of hydroxyproline in the urine]. Emmrich R; Häntzschel HJ; Häntzschel H Z Gesamte Inn Med; 1967 Apr; 22(7):193-9. PubMed ID: 5596343 [No Abstract] [Full Text] [Related]
16. Relation between urine zinc and hydroxyproline in rheumatoid arthritis and bone diseases. Ambanelli U; Ferraccioli GF; Bernardi P; Servemti G J Rheumatol; 1978; 5(4):477-9. PubMed ID: 739496 [No Abstract] [Full Text] [Related]
17. The evaluation of bone changes in patients with rheumatoid arthritis. Perlík F; Kůtová M Z Rheumatol; 1983; 42(5):261-4. PubMed ID: 6649934 [TBL] [Abstract][Full Text] [Related]
18. Zinc metabolism in rheumatoid arthritis: plasma and urinary zinc and relationship to disease activity. Naveh Y; Schapira D; Ravel Y; Geller E; Scharf Y J Rheumatol; 1997 Apr; 24(4):643-6. PubMed ID: 9101495 [TBL] [Abstract][Full Text] [Related]
19. [Diurnal excretion of catecholamines in the urine in patients with infectious nonspecific polyarthritis under complex therapy]. Novitskiĭ IaD Vrach Delo; 1969 Oct; 10():67-9. PubMed ID: 5370770 [No Abstract] [Full Text] [Related]